IDiyas

For the Inventor, By the Inventor

Newbury Park, CA, United States of America

Thomas Nixey

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 10.7

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Newbury Park, CA (US) (2006 - 2016)
  • San Diego, CA (US) (2022)

Company Filing History:

goldMedal16 out of 1,970 
 
Amgen Inc.
 patents
silverMedal1 out of 1,177 
 
Takeda Pharmaceutical Company Limited
 patents

Years Active: 2006-2022

where 'Filed Patents' based on already Granted Patents

17 patents (USPTO):
1. 11426397 - Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6 (2022-08-30),
2. 9321756 - Azole compounds as PIM inhibitors (2016-04-26),
3. 9296698 - Amino heteroaryl compounds as beta-secretase modulators and methods of use (2016-03-29),
4. 9090593 - Bicyclic compounds as Pim inhibitors (2015-07-28),
5. 8735384 - Amino heteroaryl compounds as beta-secretase modulators and methods of use (2014-05-27),
6. 8440674 - Substituted pyrimidine compounds as RAF inhibitors and methods of use (2013-05-14),
7. 8163766 - Beta-secretase modulators and methods of use (2012-04-24),
8. 7973047 - Beta-Secretase modulators and methods of use (2011-07-05),
9. 7872009 - Beta-Secretase modulators and methods of use (2011-01-18),
10. 7838676 - Beta-secretase modulators and methods of use (2010-11-23),
11. 7745484 - Beta-secretase modulators and methods of use (2010-06-29),
12. 7659276 - Melanin concentrating hormone receptor antagonist (2010-02-09),
13. 7514438 - Melanin concentrating hormone receptor antagonist (2009-04-07),
14. 7390907 - Vanilloid receptor ligands and their use in treatments (2008-06-24),
15. 7332511 - Vanilloid receptor ligands and their use in treatments (2008-02-19),

Title: The Innovative Journey of Thomas Nixey

Introduction:

Thomas Nixey, a prolific inventor based in Newbury Park, CA, has left a remarkable impact on the field of pharmaceuticals with his groundbreaking patents and contributions to the development of novel compounds for treating various diseases.

Latest Patents:

Among his impressive portfolio of 17 patents, two recent standout inventions include Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6. These compounds have shown promise in treating diseases associated with GPR6. Additionally, Nixey's work on Azole compounds as PIM inhibitors demonstrates their potential as inhibitors or modulators of Pim-1, Pim-2, and Pim-3 protein kinase activities, particularly in the field of cancer treatment.

Career Highlights:

With a rich background in the pharmaceutical industry, Thomas Nixey has lent his expertise to renowned companies such as Amgen Inc. and Takeda Pharmaceutical Company Limited. His innovative approach and dedication to advancing pharmaceutical research have led to significant advancements in drug discovery and development.

Collaborations:

Throughout his career, Thomas Nixey has collaborated with esteemed professionals in the field, including Stephen A Hitchcock and James A Brown. These partnerships have fostered a collaborative environment where ideas flourish, ultimately leading to the creation of groundbreaking pharmaceutical compounds.

Conclusion:

In conclusion, Thomas Nixey stands as a testament to the power of innovation and dedication in the field of pharmaceutical research. His patents and collaborations have not only shaped the industry but have also offered new hope in the treatment of various diseases. Nixey's legacy as an inventor continues to inspire future generations in the pursuit of scientific excellence and medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…